|
ZAK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.448300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.529800E-01 |
| Normal-vs-Stage2 |
1.828170E-04 |
| Normal-vs-Stage3 |
5.905700E-02 |
| Normal-vs-Stage4 |
4.241200E-01 |
| Stage1-vs-Stage2 |
1.895310E-03 |
| Stage1-vs-Stage3 |
2.885600E-01 |
| Stage1-vs-Stage4 |
8.568800E-01 |
| Stage2-vs-Stage3 |
3.788400E-02 |
| Stage2-vs-Stage4 |
8.408200E-02 |
| Stage3-vs-Stage4 |
6.864600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.372400E-02 |
| Normal-vs-AfricanAmerican |
3.363800E-01 |
| Normal-vs-Asian |
2.410000E-01 |
| Caucasian-vs-AfricanAmerican |
8.633000E-01 |
| Caucasian-vs-Asian |
9.878800E-01 |
| AfricanAmerican-vs-Asian |
8.647800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.425600E-02 |
| Normal-vs-Female |
1.058030E-01 |
| Male-vs-Female |
3.680200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.890600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.798400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.795500E-02 |
| Normal-vs-Age(81-100Yrs) |
6.821700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.475600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.032440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.998500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.696800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.532190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.094430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.361000E-01 |
| Classical-VS-Follicular |
2.12585504755225E-12 |
| Classical-VS-Other |
6.540000E-01 |
| Classical-VS-Normal |
8.026000E-01 |
| Tall-VS-Follicular |
5.50799999999851E-05 |
| Tall-VS-Other |
8.641600E-01 |
| Tall-VS-Normal |
3.803800E-01 |
| Follicular-VS-Other |
2.825600E-01 |
| Follicular-VS-Normal |
3.67270003298614E-09 |
| Other-VS-Normal |
6.275200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.843790E-03 |
| Normal-vs-N1 |
2.126200E-01 |
| N0-vs-N1 |
3.169600E-01 |
|
|
